Published in J Nucl Med on December 15, 2009
RNA-based therapeutics: current progress and future prospects. Chem Biol (2012) 3.01
Targeting strategies for multifunctional nanoparticles in cancer imaging and therapy. Theranostics (2012) 2.35
Activatable aptamer probe for contrast-enhanced in vivo cancer imaging based on cell membrane protein-triggered conformation alteration. Proc Natl Acad Sci U S A (2011) 1.48
Prospective of ⁶⁸Ga-radiopharmaceutical development. Theranostics (2013) 1.32
Nucleic acid aptamers: clinical applications and promising new horizons. Curr Med Chem (2011) 1.30
Aptamers from cell-based selection for bioanalytical applications. Chem Rev (2013) 1.30
DNA aptamer functionalized nanomaterials for intracellular analysis, cancer cell imaging and drug delivery. Curr Opin Chem Biol (2012) 1.05
Aptamer-conjugated nanomaterials and their applications. Adv Drug Deliv Rev (2011) 1.03
Radiolabeled nanoparticles for multimodality tumor imaging. Theranostics (2014) 1.01
Concepts and practices used to develop functional PLGA-based nanoparticulate systems. Int J Nanomedicine (2013) 0.97
Molecular imaging with nucleic acid aptamers. Curr Med Chem (2011) 0.96
Chimeric aptamers in cancer cell-targeted drug delivery. Crit Rev Biochem Mol Biol (2011) 0.96
Cancer active targeting by nanoparticles: a comprehensive review of literature. J Cancer Res Clin Oncol (2014) 0.96
Nanoparticles for multimodal in vivo imaging in nanomedicine. Int J Nanomedicine (2014) 0.96
Advance of molecular imaging technology and targeted imaging agent in imaging and therapy. Biomed Res Int (2014) 0.94
Nucleic Acid aptamers: new methods for selection, stabilization, and application in biomedical science. Biomol Ther (Seoul) (2013) 0.94
Lipid-insertion enables targeting functionalization of erythrocyte membrane-cloaked nanoparticles. Nanoscale (2013) 0.89
Current progress of aptamer-based molecular imaging. J Nucl Med (2014) 0.88
Nanoparticles for Improving Cancer Diagnosis. Mater Sci Eng R Rep (2013) 0.87
From ugly duckling to swan: unexpected identification from cell-SELEX of an anti-Annexin A2 aptamer targeting tumors. PLoS One (2014) 0.86
Aptamer identification of brain tumor-initiating cells. Cancer Res (2013) 0.86
Target-specific delivery of doxorubicin to retinoblastoma using epithelial cell adhesion molecule aptamer. Mol Vis (2012) 0.86
In vivo multimodal magnetic particle imaging (MPI) with tailored magneto/optical contrast agents. Biomaterials (2015) 0.85
Using aptamers for cancer biomarker discovery. J Nucleic Acids (2013) 0.84
Breast Cancer: Conventional Diagnosis and Treatment Modalities and Recent Patents and Technologies. Breast Cancer (Auckl) (2015) 0.83
A spherical nucleic acid platform based on self-assembled DNA biopolymer for high-performance cancer therapy. ACS Nano (2013) 0.83
DNA Aptamer Technology for Personalized Medicine. Curr Opin Chem Eng (2014) 0.81
Molecular magnetic resonance contrast agents for the detection of cancer: past and present. Semin Oncol (2011) 0.80
Aptamer-based molecular imaging. Protein Cell (2012) 0.80
Recent Developments in Active Tumor Targeted Multifunctional Nanoparticles for Combination Chemotherapy in Cancer Treatment and Imaging. J Biomed Nanotechnol (2015) 0.80
Applications of aptamers in targeted imaging: state of the art. Curr Top Med Chem (2015) 0.79
AS1411-conjugated gold nanospheres and their potential for breast cancer therapy. Oncotarget (2015) 0.78
Development of Cell-SELEX Technology and Its Application in Cancer Diagnosis and Therapy. Int J Mol Sci (2016) 0.77
Luminescent silica nanoparticles for cancer diagnosis. Curr Med Chem (2013) 0.77
General cell-binding activity of intramolecular G-quadruplexes with parallel structure. PLoS One (2013) 0.77
Fluorescence-Guided Probes of Aptamer-Targeted Gold Nanoparticles with Computed Tomography Imaging Accesses for in Vivo Tumor Resection. Sci Rep (2015) 0.76
Aptamer technology for tracking cells' status & function. Mol Cell Ther (2014) 0.76
A comparative study of glycoproteomes in androgen-sensitive and -independent prostate cancer cell lines. Mol Cell Biochem (2013) 0.76
Aptamers: versatile molecular recognition probes for cancer detection. Analyst (2016) 0.75
Effective cellular internalization of silica-coated CdSe quantum dots for high contrast cancer imaging and labelling applications. Cancer Nanotechnol (2014) 0.75
Aptamers for Targeted Drug Delivery. Pharmaceuticals (Basel) (2010) 0.75
Support vector machine classification of streptavidin-binding aptamers. PLoS One (2014) 0.75
Changes in Membrane Receptors and Ion Channels as Potential Biomarkers for Osteoarthritis. Front Physiol (2015) 0.75
Multimodal imaging for cancer detection. Nanomedicine (Lond) (2010) 0.75
Oligonucleotide-based theranostic nanoparticles in cancer therapy. Nanomedicine (Lond) (2016) 0.75
Leucyl-tRNA synthetase is an intracellular leucine sensor for the mTORC1-signaling pathway. Cell (2012) 3.38
Multiple roles of phosphoinositide-specific phospholipase C isozymes. BMB Rep (2008) 2.90
Recurrent/metastatic thyroid carcinomas false negative for serum thyroglobulin but positive by posttherapy I-131 whole body scans. Eur J Nucl Med Mol Imaging (2008) 2.55
Multifunctional uniform nanoparticles composed of a magnetite nanocrystal core and a mesoporous silica shell for magnetic resonance and fluorescence imaging and for drug delivery. Angew Chem Int Ed Engl (2008) 2.21
Performance measurement of the microPET focus 120 scanner. J Nucl Med (2007) 2.10
Novel compound 2-methyl-2H-pyrazole-3-carboxylic acid (2-methyl-4-o-tolylazo-phenyl)-amide (CH-223191) prevents 2,3,7,8-TCDD-induced toxicity by antagonizing the aryl hydrocarbon receptor. Mol Pharmacol (2006) 2.00
Diffusion-weighted MR imaging: pretreatment prediction of response to neoadjuvant chemotherapy in patients with breast cancer. Radiology (2010) 1.98
Sequential activation of phosphatidylinositol 3-kinase, beta Pix, Rac1, and Nox1 in growth factor-induced production of H2O2. Mol Cell Biol (2004) 1.82
Tissue distribution of 18F-FDG-labeled peripheral hematopoietic stem cells after intracoronary administration in patients with myocardial infarction. J Nucl Med (2006) 1.72
Identification of a compound that directly stimulates phospholipase C activity. Mol Pharmacol (2003) 1.67
Reversing the silencing of reporter sodium/iodide symporter transgene for stem cell tracking. J Nucl Med (2005) 1.59
Uniform mesoporous dye-doped silica nanoparticles decorated with multiple magnetite nanocrystals for simultaneous enhanced magnetic resonance imaging, fluorescence imaging, and drug delivery. J Am Chem Soc (2010) 1.58
Macrophage migration inhibitory factor mediates the antidepressant actions of voluntary exercise. Proc Natl Acad Sci U S A (2012) 1.53
PET evidence of neuroplasticity in adult auditory cortex of postlingual deafness. J Nucl Med (2003) 1.52
O-GlcNAcase is essential for embryonic development and maintenance of genomic stability. Aging Cell (2012) 1.49
Correlation of breast cancer subtypes, based on estrogen receptor, progesterone receptor, and HER2, with functional imaging parameters from ⁶⁸Ga-RGD PET/CT and ¹⁸F-FDG PET/CT. Eur J Nucl Med Mol Imaging (2014) 1.48
A cellular RNA-binding protein enhances internal ribosomal entry site-dependent translation through an interaction downstream of the hepatitis C virus polyprotein initiation codon. Mol Cell Biol (2004) 1.46
Safety and outcome after thrombolytic treatment in ischemic stroke patients with high-risk cardioembolic sources and prior subtherapeutic warfarin use. J Neurol Sci (2010) 1.43
Regulated intramembrane proteolysis of the p75 neurotrophin receptor modulates its association with the TrkA receptor. J Biol Chem (2003) 1.41
Persistent brain network homology from the perspective of dendrogram. IEEE Trans Med Imaging (2012) 1.41
[The incidence and clinical features of Clostridium difficile infection; single center study]. Korean J Gastroenterol (2010) 1.39
Ca(2+)-dependent inhibition of Na+/H+ exchanger 3 (NHE3) requires an NHE3-E3KARP-alpha-actinin-4 complex for oligomerization and endocytosis. J Biol Chem (2002) 1.38
Ictal SPECT using an attachable automated injector: clinical usefulness in the prediction of ictal onset zone. Acta Radiol (2009) 1.38
ID4 imparts chemoresistance and cancer stemness to glioma cells by derepressing miR-9*-mediated suppression of SOX2. Cancer Res (2011) 1.37
A prospective randomized study comparing arthroscopic single-bundle and double-bundle posterior cruciate ligament reconstructions preserving remnant fibers. Am J Sports Med (2010) 1.37
NHERF2 specifically interacts with LPA2 receptor and defines the specificity and efficiency of receptor-mediated phospholipase C-beta3 activation. Mol Cell Biol (2004) 1.37
Delayed encephalopathy of acute carbon monoxide intoxication: diffusivity of cerebral white matter lesions. AJNR Am J Neuroradiol (2003) 1.33
Preparation of a promising angiogenesis PET imaging agent: 68Ga-labeled c(RGDyK)-isothiocyanatobenzyl-1,4,7-triazacyclononane-1,4,7-triacetic acid and feasibility studies in mice. J Nucl Med (2008) 1.32
Phospholipase D activity regulates integrin-mediated cell spreading and migration by inducing GTP-Rac translocation to the plasma membrane. Mol Biol Cell (2008) 1.30
Posterior cingulate cortex atrophy and regional cingulum disruption in mild cognitive impairment and Alzheimer's disease. Neurobiol Aging (2008) 1.30
Prediction of tumor recurrence by 18F-FDG PET in liver transplantation for hepatocellular carcinoma. J Nucl Med (2009) 1.30
Serum amyloid A binding to formyl peptide receptor-like 1 induces synovial hyperplasia and angiogenesis. J Immunol (2006) 1.30
Development of a dual-luciferase reporter system for in vivo visualization of MicroRNA biogenesis and posttranscriptional regulation. J Nucl Med (2008) 1.29
Decreased frontal white-matter integrity in abstinent methamphetamine abusers. Int J Neuropsychopharmacol (2006) 1.29
Understanding of the roles of phospholipase D and phosphatidic acid through their binding partners. Prog Lipid Res (2011) 1.29
Chronic exposure to the herbicide, atrazine, causes mitochondrial dysfunction and insulin resistance. PLoS One (2009) 1.27
Glycolytic flux signals to mTOR through glyceraldehyde-3-phosphate dehydrogenase-mediated regulation of Rheb. Mol Cell Biol (2009) 1.25
Tumor targeting and imaging using cyclic RGD-PEGylated gold nanoparticle probes with directly conjugated iodine-125. Small (2011) 1.23
o-GlcNAc transferase is activated by CaMKIV-dependent phosphorylation under potassium chloride-induced depolarization in NG-108-15 cells. Cell Signal (2007) 1.23
Tractography-guided statistics (TGIS) in diffusion tensor imaging for the detection of gender difference of fiber integrity in the midsagittal and parasagittal corpora callosa. Neuroimage (2007) 1.22
Pediatric moyamoya disease: An analysis of 410 consecutive cases. Ann Neurol (2010) 1.22
Molecular imaging of a cancer-targeting theragnostics probe using a nucleolin aptamer- and microRNA-221 molecular beacon-conjugated nanoparticle. Biomaterials (2011) 1.22
Identification of peptides that antagonize formyl peptide receptor-like 1-mediated signaling. J Immunol (2004) 1.20
Functional disconnection between the prefrontal and parietal cortices during working memory processing in schizophrenia: a[15(O)]H2O PET study. Am J Psychiatry (2003) 1.19
Sparse brain network recovery under compressed sensing. IEEE Trans Med Imaging (2011) 1.19
Bioimaging of the unbalanced expression of microRNA9 and microRNA9* during the neuronal differentiation of P19 cells. FEBS J (2008) 1.17
Clinical characteristics of colonic diverticulosis in Korea: a prospective study. Korean J Intern Med (2010) 1.17
GABAA receptor phospho-dependent modulation is regulated by phospholipase C-related inactive protein type 1, a novel protein phosphatase 1 anchoring protein. J Neurosci (2004) 1.17
In vivo imaging of functional targeting of miR-221 in papillary thyroid carcinoma. J Nucl Med (2008) 1.17
Usefulness of 11C-methionine PET in the evaluation of brain lesions that are hypo- or isometabolic on 18F-FDG PET. Eur J Nucl Med Mol Imaging (2002) 1.16
Frontal glucose hypometabolism in abstinent methamphetamine users. Neuropsychopharmacology (2005) 1.14
S1P stimulates chemotactic migration and invasion in OVCAR3 ovarian cancer cells. Biochem Biophys Res Commun (2007) 1.13
Phosphatidic acid regulates systemic inflammatory responses by modulating the Akt-mammalian target of rapamycin-p70 S6 kinase 1 pathway. J Biol Chem (2003) 1.13
Proteomic analysis of tumor necrosis factor-alpha-induced secretome of human adipose tissue-derived mesenchymal stem cells. J Proteome Res (2010) 1.12
Cortical activity at rest predicts cochlear implantation outcome. Cereb Cortex (2006) 1.12
Speech perception after cochlear implantation over a 4-year time period. Acta Otolaryngol (2003) 1.11
Sensitization of epidermal growth factor-induced signaling by bradykinin is mediated by c-Src. Implications for a role of lipid microdomains. J Biol Chem (2003) 1.11
Neural correlates of clinical symptoms and cognitive dysfunctions in obsessive-compulsive disorder. Psychiatry Res (2003) 1.11
PLD2 forms a functional complex with mTOR/raptor to transduce mitogenic signals. Cell Signal (2006) 1.11
Prediction of the clinical outcome of pediatric moyamoya disease with postoperative basal/acetazolamide stress brain perfusion SPECT after revascularization surgery. Stroke (2005) 1.10
Phospholipase signalling networks in cancer. Nat Rev Cancer (2012) 1.10
HelicoVax: epitope-based therapeutic Helicobacter pylori vaccination in a mouse model. Vaccine (2011) 1.09
Preoperative differences of cerebral metabolism relate to the outcome of cochlear implants in congenitally deaf children. Hear Res (2005) 1.09
Differential features of metabolic abnormalities between medial and lateral temporal lobe epilepsy: quantitative analysis of (18)F-FDG PET using SPM. J Nucl Med (2003) 1.08
Intracranial ganglioglioma: preoperative characteristics and oncologic outcome after surgery. J Neurooncol (2002) 1.07
18F-FDG PET/CT in mediastinal lymph node staging of non-small-cell lung cancer in a tuberculosis-endemic country: consideration of lymph node calcification and distribution pattern to improve specificity. Eur J Nucl Med Mol Imaging (2009) 1.06
Correlation of perfusion parameters on dynamic contrast-enhanced MRI with prognostic factors and subtypes of breast cancers. J Magn Reson Imaging (2012) 1.06
A case of acute cholestatic hepatitis associated with the seeds of Psoralea corylifolia (Boh-Gol-Zhee). Clin Toxicol (Phila) (2005) 1.06
Periostin-binding DNA aptamer inhibits breast cancer growth and metastasis. Mol Ther (2013) 1.06
Relationship between Gastrointestinal F-18-fluorodeoxyglucose Accumulation and Gastrointestinal Symptoms in Whole-Body PET. Clin Positron Imaging (1999) 1.06
Human mesenchymal stem cell differentiation to the osteogenic or adipogenic lineage is regulated by AMP-activated protein kinase. J Cell Physiol (2012) 1.05
Initial results of simultaneous PET/MRI experiments with an MRI-compatible silicon photomultiplier PET scanner. J Nucl Med (2012) 1.05
The interaction of phospholipase C-beta3 with Shank2 regulates mGluR-mediated calcium signal. J Biol Chem (2005) 1.05
FDG uptake, glucose transporter type 1, and Ki-67 expressions in non-small-cell lung cancer: correlations and prognostic values. Eur J Radiol (2007) 1.04
Diffusion tensor MRI as a diagnostic tool of upper motor neuron involvement in amyotrophic lateral sclerosis. J Neurol Sci (2004) 1.04
Interferon-gamma promotes abortion due to Brucella infection in pregnant mice. BMC Microbiol (2005) 1.04
Imaging sensitivity of dedicated positron emission mammography in relation to tumor size. Breast (2011) 1.04
(18)F-FDG PET in localization of frontal lobe epilepsy: comparison of visual and SPM analysis. J Nucl Med (2002) 1.04
Lysophosphatidylcholine activates adipocyte glucose uptake and lowers blood glucose levels in murine models of diabetes. J Biol Chem (2009) 1.04
Combined encephaloduroarteriosynangiosis and bifrontal encephalogaleo(periosteal)synangiosis in pediatric moyamoya disease. Neurosurgery (2002) 1.03
Differential activation of formyl peptide receptor-like 1 by peptide ligands. J Immunol (2003) 1.03
Evolutionary conservation in multiple faces of protein interaction. Proteins (2009) 1.02
Molecular cloning and characterization of a novel phospholipase C, PLC-eta. Biochem J (2005) 1.02
Localization of phospholipase D1 to caveolin-enriched membrane via palmitoylation: implications for epidermal growth factor signaling. Mol Biol Cell (2002) 1.02
Whole-brain functional networks in cognitively normal, mild cognitive impairment, and Alzheimer's disease. PLoS One (2013) 1.02
Standard anterior cruciate ligament reconstruction versus isolated single-bundle augmentation with hamstring autograft. Arthroscopy (2009) 1.02
11C-methionine PET as a prognostic marker in patients with glioma: comparison with 18F-FDG PET. Eur J Nucl Med Mol Imaging (2004) 1.02
Comparison of segmentation-based attenuation correction methods for PET/MRI: evaluation of bone and liver standardized uptake value with oncologic PET/CT data. J Nucl Med (2012) 1.02
CXCL12 secreted from adipose tissue recruits macrophages and induces insulin resistance in mice. Diabetologia (2014) 1.01
Molecular beacon-based bioimaging of multiple microRNAs during myogenesis. Biomaterials (2010) 1.01